Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
FEBS J ; 276(22): 6701-13, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19843159

ABSTRACT

Complex IV is the terminal enzyme of the mitochondrial respiratory chain. In humans, biogenesis of complex IV involves the coordinated assembly of 13 subunits encoded by both mitochondrial and nuclear genomes. The early stages of complex IV assembly involving mitochondrial DNA-encoded subunits CO1 and CO2 have been well studied. However, the latter stages, during which many of the nuclear DNA-encoded subunits are incorporated, are less well understood. Using in vitro import and assembly assays, we found that subunits Cox6a, Cox6b and Cox7a assembled into pre-existing complex IV, while Cox4-1 and Cox6c subunits assembled into subcomplexes that may represent rate-limiting intermediates. We also found that Cox6a and Cox7a are incorporated into a novel intermediate complex of approximately 250 kDa, and that transition of subunits from this complex to the mature holoenzyme had stalled in the mitochondria of patients with isolated complex IV deficiency. A number of complex IV subunits were also found to integrate into supercomplexes containing combinations of complex I, dimeric complex III and complex IV. Subunit assembly into these supercomplexes was also observed in mitochondria of patients in whom monomeric complex IV was selectively reduced. We conclude that newly imported nuclear DNA-encoded subunits can integrate into the complex IV holoenzyme and supercomplex forms by associating with pre-existing subunits and intermediate assembly complexes.


Subject(s)
Electron Transport Complex IV/metabolism , Mitochondria/metabolism , Mitochondrial Diseases/metabolism , Cells, Cultured , Electron Transport Complex IV/chemistry , Electron Transport Complex IV/genetics , Electrophoresis, Polyacrylamide Gel , Humans , Mitochondrial Diseases/genetics , Mitochondrial Membranes/metabolism , Mitochondrial Proteins/chemistry , Mitochondrial Proteins/genetics , Mitochondrial Proteins/metabolism , Phosphorylation , Protein Structure, Secondary , Yeasts/genetics , Yeasts/metabolism
2.
Am J Hum Genet ; 83(4): 468-78, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18940309

ABSTRACT

Complex I (NADH:ubiquinone oxidoreductase) is the first and largest multimeric complex of the mitochondrial respiratory chain. Human complex I comprises seven subunits encoded by mitochondrial DNA and 38 nuclear-encoded subunits that are assembled together in a process that is only partially understood. To date, mutations causing complex I deficiency have been described in all 14 core subunits, five supernumerary subunits, and four assembly factors. We describe complex I deficiency caused by mutation of the putative complex I assembly factor C20orf7. A candidate region for a lethal neonatal form of complex I deficiency was identified by homozygosity mapping of an Egyptian family with one affected child and two affected pregnancies predicted by enzyme-based prenatal diagnosis. The region was confirmed by microcell-mediated chromosome transfer, and 11 candidate genes encoding potential mitochondrial proteins were sequenced. A homozygous missense mutation in C20orf7 segregated with disease in the family. We show that C20orf7 is peripherally associated with the matrix face of the mitochondrial inner membrane and that silencing its expression with RNAi decreases complex I activity. C20orf7 patient fibroblasts showed an almost complete absence of complex I holoenzyme and were defective at an early stage of complex I assembly, but in a manner distinct from the assembly defects caused by mutations in the assembly factor NDUFAF1. Our results indicate that C20orf7 is crucial in the assembly of complex I and that mutations in C20orf7 cause mitochondrial disease.


Subject(s)
Methyltransferases/genetics , Mitochondrial Diseases/genetics , Mutation , Computational Biology/methods , DNA Mutational Analysis , Electron Transport Complex I/metabolism , Female , Genetic Markers , Homozygote , Humans , Intracellular Membranes/metabolism , Male , Methyltransferases/physiology , Mitochondrial Proteins , Models, Genetic , Mutation, Missense , Pedigree , RNA Interference
3.
Gait Posture ; 27(3): 376-86, 2008 Apr.
Article in English | MEDLINE | ID: mdl-17583512

ABSTRACT

Axial tibiofemoral joint contact forces were non-invasively determined for two high range of motion (high flexion) squatting activities. An electromagnetic motion tracking system and a non-conductive force platform were used to collect kinematic and kinetic data. An innovative scaling method was used to model subject-specific muscle group moment arms. One subject attained a peak axial tibiofemoral joint contact force of 49.7 N/kg during squatting at 149.9 degrees knee flexion. Average joint angles and average axial joint contact forces were calculated for each of the activities in order to facilitate a comparison with stair climbing data. Compared to stair climbing, the maximum average joint contact forces during the squatting activities occurred at significantly higher flexion angles (p<0.05.) The relative simplicity of the method makes it useful for application to large subject groups from diverse regions. The results of this study can be applied to the diagnosis and treatment of pathologies, and to the development of high range of motion (ROM) knee replacements.


Subject(s)
Femur/physiology , Knee Joint/physiology , Range of Motion, Articular/physiology , Tibia/physiology , Biomechanical Phenomena , Female , Humans , Male , Middle Aged , Movement/physiology , Stress, Mechanical , Weight-Bearing
SELECTION OF CITATIONS
SEARCH DETAIL
...